All Stories

  1. Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2019, Dove Medical Press

    Dr Timothy E Albertson

  2. The Salford Lung Study: a pioneering comparative effectiveness approach to COPD and asthma in clinical trials

    Article • Pragmatic and Observational Research, September 2017, Dove Medical Press

    Dr Timothy E Albertson

  3. Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy

    Article • Drug Design Development and Therapy, December 2016, Dove Medical Press

    Dr Timothy E Albertson

  4. fluticasone and vilanterol in asthma

    Article • Therapeutic Advances in Respiratory Disease, December 2015, SAGE Publications

    Dr Timothy E Albertson

  5. Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol

    Article • Patient Preference and Adherence, February 2015, Taylor & Francis

    Dr Timothy E Albertson

  6. New combination treatments in the management of asthma: focus on fluticasone/vilanterol

    Article • Journal of Asthma and Allergy, May 2014, Taylor & Francis

    Dr Timothy E Albertson